Login / Signup
Guiling Li
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 3
Top Topics
Respiratory Syndrome Coronavirus
End Stage Renal Disease
Clinical Trial
Ejection Fraction
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Irish journal of medical science
Current microbiology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jusheng An
,
Jie Tang
,
Benjamin X Li
,
Huihua Xiong
,
Hui Qiu
,
Lin Luo
,
Li Wang
,
Danbo Wang
,
Qi Zhou
,
Qin Xu
,
Honglin Song
,
Yunyan Zhang
,
Hongping Zhang
,
Yujie Li
,
Xiaohui Yu
,
Jing Zhang
,
Rachel Ng
,
Wayne Zhao
,
Michael Wong
,
Xiangrong Dai
,
Guiling Li
,
Ling-Ying Wu
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study.
Clinical cancer research : an official journal of the American Association for Cancer Research
28 (23) (2022)
Yao Jiang
,
Xiuqi Wei
,
Hui Wang
,
Guiling Li
Duration of antibody responses following severe acute respiratory syndrome coronavirus 2 infection.
Irish journal of medical science
191 (6) (2022)
Yao Jiang
,
Yingchao Zhao
,
Guiling Li
The Duration and Determinants of Anti-SARS-CoV-2 Immunoglobulin G in Cancer Patients with SARS-CoV-2 Infection: A Longitudinal Study.
Current microbiology
79 (8) (2022)